Cargando…
Targeting c-Myc Unbalances UPR towards Cell Death and Impairs DDR in Lymphoma and Multiple Myeloma Cells
Multiple myeloma (MM) and primary effusion lymphoma (PEL) are aggressive hematological cancers, for which the search for new and more effective therapies is needed. Both cancers overexpress c-Myc and are highly dependent on this proto-oncogene for their survival. Although c-Myc inhibition has been s...
Autores principales: | Arena, Andrea, Romeo, Maria Anele, Benedetti, Rossella, Gilardini Montani, Maria Saveria, Cirone, Mara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033049/ https://www.ncbi.nlm.nih.gov/pubmed/35453482 http://dx.doi.org/10.3390/biomedicines10040731 |
Ejemplares similares
-
Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas
por: Benedetti, Rossella, et al.
Publicado: (2022) -
Role of UPR Sensor Activation in Cell Death–Survival Decision of Colon Cancer Cells Stressed by DPE Treatment
por: Benedetti, Rossella, et al.
Publicado: (2021) -
c-Myc Sustains Pancreatic Cancer Cell Survival and mutp53 Stability through the Mevalonate Pathway
por: Romeo, Maria Anele, et al.
Publicado: (2022) -
PBA Preferentially Impairs Cell Survival of Glioblastomas Carrying mutp53 by Reducing Its Expression Level, Stabilizing wtp53, Downregulating the Mevalonate Kinase and Dysregulating UPR
por: Romeo, Maria Anele, et al.
Publicado: (2020) -
HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells
por: Gonnella, Roberta, et al.
Publicado: (2023)